Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Multiple Outcome Evaluation of Radiation Therapy Using the MR-Linac Study

NCT04075305 is registered in ClinicalTrials.gov with UMC Utrecht as lead sponsor.

NCT NCT04075305
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04075305 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Multiple Outcome Evaluation of Radiation Therapy Using the MR-Linac Study
Lead sponsor
UMC Utrecht
Phase
Observational
Overall status
Recruiting
Start date
February 1, 2019
Completion date
August 1, 2030
Enrollment
8,000 (estimated)
Sites
18

Conditions

As the registry lists them; a condition with its own page is linked.

bladder cancer, bladder neoplasm, brain cancer, brain tumor, breast cancer, breast tumor, esophageal cancer, esophageal neoplasm, esophageal tumor, esophagus cancer, esophagus neoplasm, esophagus tumor, gynecologic cancer, gynecologic tumor, head and neck cancer, head and neck neoplasms, head and neck tumor, liver cancer, liver metastases, liver neoplasms, lung cancer, lung neoplasm, lung tumor, neoplasms, oligometastases, oncology, pancreatic cancer, pancreatic neoplasms, pancreatic tumor, prostate cancer, prostate neoplasm, prostate tumor, quality of life, radiation toxicity, rectal cancer, rectal neoplasms, rectal tumor, tumor